CONSEQUENCES OF ABRUPT DISCONTINUATION OF ANTI TUBERCULAR THERAPY (ATT) DUE TO ADVERSE DRUG REACTION (ADRS): A TERTIARY HOSPITAL BASED STUDY. PharmaNexus Bull 2026, 2 (2), 1-5.